Clin2
NCT06929962Likely a fitRecruiting

VA dual sequential therapy for H. pylori gastritis

Helicobacter Pylori Infection

Part of Infections clinical trials.

This trial tests a new two-step antibiotic treatment for adults with chronic gastritis caused by H. pylori bacteria. If you have not been treated for H. pylori before and are between 18 and 70, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
600 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • Age between 18 and 70 years old
  • Diagnosed with chronic gastritis (confirmed by an endoscopy within the last 6 months)
  • Had a positive breath test for H. pylori within the last month
  • Never been treated for H. pylori before
  • Not allergic to any of the trial medications

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07242456Recruiting· Phase 2/Phase 3
Comparing two treatments for H. pylori infection

This study tests two different combinations of medications to treat H. pylori, a stomach bacteria that can cause ulcers. You would take one of the two combinations for a short time to see which works better at getting rid of the infection.

Hangzhou, Zhejiang
NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka
NCT07624422Not yet recruiting· Phase 4
Helicobacter pylori infection treatment study

This study tests a new antibiotic combination to treat stomach infections caused by H. pylori bacteria. It may help clear the infection and reduce stomach problems.

Damascus
NCT06959368Recruiting· Phase 4
New H. pylori treatment vs standard triple therapy

This trial compares a newer drug (vonoprazan) plus antibiotics to the standard triple therapy for eradicating H. pylori infection in the stomach. It may be a good option if you have stomach symptoms like indigestion, acid reflux, or a non-bleeding ulcer and have not been treated for H. pylori before.

Hyderabad, Telangana
NCT07439445Recruiting
Simplified treatment for H. pylori guided by a stool test

This trial tests a simpler two-drug treatment for H. pylori infection, chosen based on a stool test that checks if the bacteria are resistant to clarithromycin. It may help people who have not been treated before avoid unnecessary antibiotics.

Beijing, Beijing Municipality
NCT07358130Recruiting
Comparing two treatments for H. pylori infection

This trial tests two different ways to treat Helicobacter pylori (H. pylori), a bacteria that can cause stomach ulcers. One treatment combines three medicines (bismuth, amoxicillin, and vonoprazan), and the other uses four medicines (bismuth quadruple therapy). The goal is to see which works better.

Kaohsiung City

Hear when a new Helicobacter Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.